George A. Scangos

2017 - Biogen

In 2017, George A. Scangos earned a total compensation of $7.5M as Former Chief Executive Officer at Biogen, a 58% decrease compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$159,968
Salary$60,065
Other$7,255,796
Total$7,475,829

Scangos received $7.3M in other compensation, accounting for 97.06% of the total pay in 2017.

Scangos also received $160K of change in pension value and nonqualified deferred compensation earnings and $60.1K in salary.

Rankings

In 2017, George A. Scangos' compensation ranked 993rd out of 13,916 executive pay records tracked by us. In other words, Scangos earned more than 92.9% of all executives tracked by us in 2017.

ClassificationRankingPercentile
All
993
out of 13,916
93rd
Manufacturing
Division
339
out of 5,489
94th
Chemicals And Allied Products
Major group
88
out of 1,934
95th
Drugs
Industry group
59
out of 1,601
96th
Biological Products, Except Diagnostic Substances
Industry
9
out of 290
97th
Source: SEC filing on April 27, 2018.

Scangos' colleagues

We found eight more compensation records of executives who worked with George A. Scangos at Biogen in 2017.

2017

Michel Vounatsos

Biogen

Chief Executive Officer

2017

Kenneth DiPietro

Biogen

Former Executive Vice President, Human Resources

2017

Michael Ehlers

Biogen

Executive Vice President, Research & Development

2017

Susan Alexander

Biogen

Chief Legal Officer

2017

Paul McKenzie

Biogen

Executive Vice President, Pharmaceutical Operations & Technology

2017

Paul Clancy

Biogen

Chief Financial Officer

2017

Gregory Covino

Biogen

Chief Accounting Officer

2017

Jeffrey Capello

Biogen

Chief Financial Officer

You may also like